
Shiv Texchem Ltd
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Shiv Texchem Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
IPO Snapshot
Key metrics and details at a glance.

Price Band
₹166
Per Share
Lot Size
800 Shares

Minimum Investment
₹1,32,800

Issue Size
₹101.35 Cr

Face Value
₹10
Per Share
IPO Type
Book Building - SME

Retail Quota
35%

QIB Quota
50%

NII Quota
15%
IPO Timeline
Important dates for your applying strategy.
Subscription Status
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Shiv Texchem Ltd
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
100%
Issue Type
Book Building - SME
ISIN
INE0YRO01015
About the Company
Shiv Texchem Limited is primarily engaged in the business of importing and distributing hydrocarbon-based chemicals that are crucial raw materials for a wide range of industries including paints, coatings, printing inks, agro-chemicals, polymers, pharmaceuticals, and industrial chemicals. Serving as preferred sourcing partners, the company aggregates customer orders and engage with global producers and suppliers to negotiate pricing, specifications, quantities, and delivery schedules.
Industry Overview
India has been one of the largest consumers of chemicals & petrochemical products in Asia Pacific region for the bulk of the last 10 - 15 years. The rapid growth in India's manufacturing infrastructure during this time period have created strong demand for a wide range of chemical & petrochemical input materials and intermediates. As India became one of the fastest growing economies in the world, the annual growth in demand for chemical & petrochemical input materials and intermediates too increased at a fast clip.
Company History
Shiv Texchem Limited was originally incorporated as `Shiv Texchem Private Limited' as a private limited company in Mumbai under the provisions of the Companies, Act, 1956, pursuant to a certificate of incorporation dated March 31, 2005, issued by Registrar of Companies, Maharashtra, Mumbai ("ROC"/"Registrar of Companies"). Subsequently, the Company was converted into a public limited company pursuant to a special resolution passed by its Shareholders at an Extra-ordinary General Meeting held on June 11, 2024, and the name of the Company was changed to `Shiv Texchem Limited and a fresh certificate of incorporation consequent upon conversion dated July 05, 2024 was issued by the Registrar of Companies.
Products & Services
- The Company is primarily engaged in the business of importing and distributing hydrocarbon-based chemicals.
Growth Strategy
- Further penetrate hydrocarbon and petrochemical market in India.
- Strengthening existing customer relationships and build new customer relationship through its product portfolio.
- Further optimising its working capital cycle.
- Expand its Product Portfolio and diversify into additional business segments.
Customer Base
Wholesaler and Retailer
Financial Performance
Revenue, profit after tax and total assets across the last 3 reported financial years.
Revenue
Amount in ₹ crore
Profit After Tax (PAT)
Amount in ₹ crore
Total Assets
Amount in ₹ crore
Figures in ₹ crore, on a standalone basis, as reported for FY24 to FY26.
Objects of the Issue
How the company plans to utilize IPO proceeds.
Use of Proceeds
The funds raised through this IPO will be used for:
Initial public issue of upto 61,05,600 equity shares of face value of Rs. 10/- each of Shiv Texchem Limited ("STL" or the "Company" or the "Issuer") for cash at a price of Rs. 166/- per equity share including a share premium of Rs. 156/- per equity share (the "Issue Price") aggregating to Rs. 101.35 crores ("The Issue"), of which 3,05,600 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 166/- per equity share including a share premium of Rs. 156/- per equity share aggregating to Rs. 5.07 crores was reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of 58,00,000 equity shares of face value of Rs. 10/- each at a price of Rs. 166/- per equity share including a share premium of Rs. 156/- per equity share aggregating to Rs. 96.28 crores is hereinafter referred to as the "Net Issue". The issue and the net issue will constitute 26.35 % and 25.03 %, respectively, of the post issue paid up equity share capital of the company.
*Subject to approvals and market conditions.
Strengths & Risks
Key competitive advantages and factors to consider before investing.
- Diversified product portfolio.
- Long term relationship with customers and suppliers.
- Effective management of supply chain including storage, handling and logistics system.
- Experienced management team.
- Ensuring price, specifications, quantity and delivery schedule of the products.
- The company derives a significant part of its revenue from a group of select products. If the company fails to offer any of these products, its business, financial condition and results of operations may be adversely affected.
- The company is dependent on limited number of suppliers for supply of its traded products and the company has not made any long term supply arrangement with its suppliers. In an eventuality where the company suppliers are unable to deliver it the required materials in a time-bound manner it have a material adverse effect on its business operations and profitability.
- The company does not have long term agreements with its customers and relies on purchase orders for delivery of its products. Loss of one or more of its customers or a reduction in their demand for the company products could adversely affect its business, results of operations and financial condition.
- Its operations are heavily dependent on industries where products are supplied, which includes paints and coatings, printing inks, agro-chemical products, specialty polymers, pharmaceuticals products, specialty industrial chemicals, etc.
- Its business is working capital intensive involving high level of inventories and trade receivables. The company requires substantial financing for its business operations. The company indebtedness and the conditions and restrictions imposed on by its financing arrangements could adversely affect the company ability to conduct its business.